October 18, 2023 01:23 PM EDT
Pharma

Pfiz­er agrees to $2M set­tle­ment deal over gen­der dis­crim­i­na­tion al­le­ga­tions

Nicole DeFeudis

Editor

Pfiz­er will pay $2 mil­lion to clear al­le­ga­tions from the US De­part­ment of La­bor that it un­der­paid fe­male em­ploy­ees at its New York City head­quar­ters …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

Post-Hoc: Biose­cure is dead. Long live Biose­cure? 

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

A service from the Financial Times